Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry.

Li, XinyuHoogenveen, RudolfEl Alili, MohamedKnies, SaskiaWang, JunfengBeulens, Joline W JElders, Petra J MNijpels, Gielvan Giessen, AnoukhFeenstra, Talitha L2023-06-192023-06-192023-06-103730065210.1007/s40273-023-01286-3http://hdl.handle.net/10029/626771en© 2023. The Author(s).Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry.Article1179-2027PharmacoEcon 2023; 41(10):1249-1262